id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S3581 R7150 |
Nezvalová-Henriksen (Control unexposed, disease free), 2013 | Gestational age < 37 weeks | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, disease free excluded | Adjustment: Yes |
0.85 [0.61;1.17] excluded (control group) |
41/575 13,013/178,565 | 13,054 | 575 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3582 R7168 |
Nezvalová-Henriksen (Control unexposed, sick), 2013 | Gestational age < 37 weeks | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, sick | Adjustment: No | 0.60 [0.38;0.95] C | 41/575 41/364 | 82 | 575 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3531 R6977 |
Olesen (Control unexposed, disease free), 2000 | Preterm delivery (< 37 weeks) | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, disease free excluded | Adjustment: Yes |
3.30 [1.30;8.50] excluded (control group) |
5/34 950/15,995 | 955 | 34 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3530 R6975 |
Olesen (Control unexposed, sick), 2000 | Preterm delivery (< 37 weeks) | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, sick | Adjustment: Yes | 6.30 [1.20;32.00] | 5/34 3/89 | 8 | 34 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3490 R6736 |
Shuhaiber (Control exposed to other treatments), 1998 | Gestational age < 37 | during pregnancy (anytime or not specified) | prospective cohort | exposed to other treatment, sick excluded | Adjustment: No |
0.50 [0.20;1.24] C excluded (control group) |
8/82 16/90 | 24 | 82 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3491 R6740 |
Shuhaiber (Control unexposed, disease free), 1998 | Gestational age < 37 | during pregnancy (anytime or not specified) | prospective cohort | unexposed, disease free | Adjustment: No | 1.86 [0.58;5.93] C | 8/82 5/91 | 13 | 82 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 3 studies | 1.60 [0.43;5.97] | 103 | 691 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Control unexposed, sick; 2: Control unexposed, sick; 3: Control unexposed, disease free;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 3490, 3531, 3581